NSABP FOUNDATION INC
Mission Statement
Design and conduct clinical studies in breast and colorectal cancer to improve treatment and advance the standard of care. Since inception in 1957, the NSABP Foundation has designed and led myriad clinical trials pioneering new standards for treating breast and colorectal cancer. Motivation for the Foundation and its supporting networks remains directly in line with those of the founding physicians from the 1950s. We continue to leverage our unique capabilities to build a better understanding of cancer and develop advancements to improve the standard of care for those diagnosed with these debilitating diseases. NSABP is a nonprofit organization. Proceeds from government and industry-funded clinical trials are relied upon to cover our operational costs.
Financial Overview — FY 2023
Compared with Peers
FY 2023| Ratio | This org | Peer median | Position (P10 → P90) | |
|---|---|---|---|---|
|
Program expense ratio
Program expenses / total expenses
· higher is better
|
101.2% | 82.7% |
P10P90
|
Top quarter |
|
Admin expense ratio
Management and general / total expenses
· lower is better
|
-1.2% | 13.5% |
P10P90
|
Top quarter |
|
Fundraising expense ratio
Fundraising expenses / total expenses
· lower is better
|
0.0% | 0.0% |
P10P90
|
Top quarter |
|
Operating reserve
Months of expenses covered by net assets
· higher is better
|
18.5 mo | 12.6 mo |
P10P90
|
Above median |
|
Liabilities to assets
Total liabilities / total assets
· lower is better
|
42.5% | 29.0% |
P10P90
|
Below median |
|
Revenue concentration
Share of revenue from the largest source
· lower is better
|
83.2% | 91.9% |
P10P90
|
Above median |
|
Revenue growth
Year over year revenue growth
|
33.6% | 7.4% |
P10P90
|
|
|
Expense growth
Year over year expense growth
|
13.9% | 10.1% |
P10P90
|
|
|
Surplus margin
Surplus as a share of revenue
|
17.4% | -2.4% |
P10P90
|
Financial History
| Year | Revenue | Expenses | Net Assets | Program % | Staff |
|---|---|---|---|---|---|
| 2023 | $44.2M | $36.5M | $56.3M | 101.2% | 114 |
| 2022 | $33.1M | $32.1M | $43.3M | 93.7% | 114 |
| 2021 | $55.9M | $47.6M | N/A | — | 108 |
Donor Reviews
Write a ReviewBe the first to share your experience with this organization.